|
2010 |
| May 5, 2010 |
Novocell Becomes ViaCyte, Inc, as it Accelerates Pre-clinical Development of a Stem Cell Derived Treatment for Diabetes
|
| May 5, 2010 |
ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes
|
|
2009 |
| Oct 28, 2009 |
Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
|
| June 3, 2009 |
Novocell Obtains U.S. Patent for Drug Screening Human Embryonic Cell Derived-Endoderm Cells
|
| May 19, 2009 |
Novocell Awarded Patent for Innovative Stem Cell Therapy for Diabetes
|
| May 11, 2009 |
Novocell Names John West Chief Executive Officer
|
| May 6, 2009 |
Novocell Receives Grant Awards from California Institute for Regenerative Medicine for Stem Cell Therapy Development
|
| Mar 31, 2009 |
Novocell Awarded Seminal Stem Cell Patent
|
| Mar 2, 2009 |
Novocell Honored by National Diabetes Organization
|
|
2008 |
| Dec 19, 2008 |
Novocell Announces Non-Exclusive Drug Discovery Collaboration with Pfizer
|
| Dec 9, 2008 |
Novocell Announces Collobaration with World-Renowned Stem Cell Researcher Shinya Yamanaka of Kyoto University
|
| Nov 25, 2008 |
Novocell CEO to Head Juvenile Diabetes Research Foundation (JDRF)
|
| Sep 17, 2008 |
Novocell Awarded Landmark U.S. Patents for Innovative Stem Cell Technologies
|
| June 9, 2008 |
Novocell's Emmanuel Baetge, Ph.D., Featured in Forbes cover story: "Stem Cells Get Real"
|
| Feb 20, 2008 |
Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice
|
|
2007 |
| Oct 25, 2007 |
Novocell Appoints Orville G. Kolterman, M.D. to Board of Directors
|
| Sep 7, 2007 |
National Stem Cell Bank Announces Addition of New Cell Lines
|
| Aug 30, 2007 |
Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways with Proliferation and Self-Renewal of Human Embryonic Stem Cells
|
| Aug 14, 2007 |
Novocell and Invitrogen Launch Breakthrough Media for Human Embryonic Stem Cells
|
| July 16, 2007 |
Novocell raises $25 Million - Series C to Support Continued Development of Stem Cell Therapy
|
|
2006 |
| Oct 19, 2006 |
Nature Biotechnology Announces Publication of Paper Describing Creation of Insulin-Producing Cells from Human Embryonic Stem Cells by Novocell's K.A. D'Amour, et al.
|
| Oct 19, 2006 |
Novocell Announces Creation of Insulin-Producing Pancreatic Endocrine Cells from Human Embryonic Stem Cells
|
